Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma

Saved in:
Bibliographic Details
Main Authors: Elizabeth K. O’Donnell, Jennifer E. Carroll, Jaqueline Perry, Katherine Padgett, Benjamin Harris, Vidhi Patel, Omar Nadeem, Areej El-Jawahri, Irene M. Ghobrial, Catherine R. Marinac
Format: Article
Language:English
Published: Elsevier 2025-04-01
Series:Blood Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2473952925000692
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849725680383688704
author Elizabeth K. O’Donnell
Jennifer E. Carroll
Jaqueline Perry
Katherine Padgett
Benjamin Harris
Vidhi Patel
Omar Nadeem
Areej El-Jawahri
Irene M. Ghobrial
Catherine R. Marinac
author_facet Elizabeth K. O’Donnell
Jennifer E. Carroll
Jaqueline Perry
Katherine Padgett
Benjamin Harris
Vidhi Patel
Omar Nadeem
Areej El-Jawahri
Irene M. Ghobrial
Catherine R. Marinac
author_sort Elizabeth K. O’Donnell
collection DOAJ
format Article
id doaj-art-6f429e37a49d490eafd2ae2f54a60c16
institution DOAJ
issn 2473-9529
language English
publishDate 2025-04-01
publisher Elsevier
record_format Article
series Blood Advances
spelling doaj-art-6f429e37a49d490eafd2ae2f54a60c162025-08-20T03:10:24ZengElsevierBlood Advances2473-95292025-04-01981984198710.1182/bloodadvances.2024015575Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myelomaElizabeth K. O’Donnell0Jennifer E. Carroll1Jaqueline Perry2Katherine Padgett3Benjamin Harris4Vidhi Patel5Omar Nadeem6Areej El-Jawahri7Irene M. Ghobrial8Catherine R. Marinac9Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Correspondence: Elizabeth K. O’Donnell, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215;Medical Oncology, Dana-Farber Cancer Institute, Boston, MAMedical Oncology, Dana-Farber Cancer Institute, Boston, MAMedical Oncology, Dana-Farber Cancer Institute, Boston, MAMedical Oncology, Dana-Farber Cancer Institute, Boston, MAMedical Oncology, Dana-Farber Cancer Institute, Boston, MAMedical Oncology, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MAHarvard Medical School, Boston, MA; Medical Oncoloy, Massachusetts General Hospital, Boston, MAMedical Oncology, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MAMedical Oncology, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MAhttp://www.sciencedirect.com/science/article/pii/S2473952925000692
spellingShingle Elizabeth K. O’Donnell
Jennifer E. Carroll
Jaqueline Perry
Katherine Padgett
Benjamin Harris
Vidhi Patel
Omar Nadeem
Areej El-Jawahri
Irene M. Ghobrial
Catherine R. Marinac
Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
Blood Advances
title Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
title_full Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
title_fullStr Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
title_full_unstemmed Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
title_short Distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
title_sort distress and symptom burden in patients with monoclonal gammopathy of undetermined significance and smoldering myeloma
url http://www.sciencedirect.com/science/article/pii/S2473952925000692
work_keys_str_mv AT elizabethkodonnell distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT jenniferecarroll distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT jaquelineperry distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT katherinepadgett distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT benjaminharris distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT vidhipatel distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT omarnadeem distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT areejeljawahri distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT irenemghobrial distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma
AT catherinermarinac distressandsymptomburdeninpatientswithmonoclonalgammopathyofundeterminedsignificanceandsmolderingmyeloma